NHLH1
Helix-loop-helix protein 1
Also known as: bHLHa35, HEN1, HEN1_HUMAN, NSCL, NSCL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02575
- Gene
- NHLH1
- Ensembl
- ENSG00000171786
- Chromosome
- 1
- Canonical length
- 133 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
The helix-loop-helix (HLH) proteins are a family of putative transcription factors, some of which have been shown to play an important role in growth and development of a wide variety of tissues and species. Four members of this family have been clearly implicated in tumorigenesis via their involvement in chromosomal translocations in lymphoid tumors: MYC (MIM 190080), LYL1 (MIM 151440), E2A (MIM 147141), and SCL (MIM 187040).[supplied by OMIM, Nov 2002]
Canonical amino-acid sequenceUniProt
133 residues, UniProt reviewed canonical sequence.
>Q02575|NHLH1
1 MMLNSDTMEL DLPPTHSETE SGFSDCGGGA GPDGAGPGGP GGGQARGPEP GEPGRKDLQH
61 LSREERRRRR RATAKYRTAH ATRERIRVEA FNLAFAELRK LLPTLPPDKK LSKIEILRLA
121 ICYISYLNHV LDVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NHLH1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 1.7 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 1.7 nTPM
- cerebellum: 1.1 nTPM
- hypothalamus: 1 nTPM
- hippocampal formation: 0.9 nTPM
- cerebral cortex: 0.8 nTPM
- spinal cord: 0.8 nTPM
Single-cell type
- neutrophils: 9.5 nCPM
- mesothelial cells: 4.8 nCPM
- kupffer cells: 3.1 nCPM
- monocytes: 2.2 nCPM
- cone photoreceptor cells: 2.1 nCPM
- pdcs: 2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- spinal cord: 5.2 nTPM
- basal ganglia: 3.1 nTPM
- midbrain: 2.6 nTPM
- cerebral cortex: 2.4 nTPM
- medulla oblongata: 2.4 nTPM
- hippocampal formation: 2.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0.26
- gnomAD missense Z
- 1.04
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- central nervous system development
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NHLH1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NHLH1 as an antibody target. Whether an autoantibody or antibody against NHLH1 could matter depends on whether native NHLH1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NHLH1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NHLH1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...